Fighting Corona AND Cancer Together!​

The Coronavirus is keeping cancer patients from getting the treatment they desperately need. Now more than ever we need to advocate for patients and help people fight cancer. We’ll be updating this page daily with helpful resources and patient stories. Subscribe below to receive a weekly digest of our updates

Cancer Trials Suspended Due to COVID-19

Clinical Trial TitleTrial SponsorNCT ID
Collecting and Storing Tissue Samples From Women With or Without Breast CancerNational Cancer Institute (NCI)NCT00899301
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall SurvivalInstitut Claudius RegaudNCT01574170
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial LesionsAIDS Malignancy ConsortiumNCT02135419
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant Metastatic Prostate CancerMadison Vaccines IncNCT02499835
Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic ImagingBoston Medical CenterNCT02510456
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesFred Hutchinson Cancer Research CenterNCT02706392
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT ImagingNational Cancer Institute (NCI)NCT02773238
Cost Utility of Radical Surgery in Ovarian CancerInstitut Claudius RegaudNCT02854215
Evaluation of an Organized Consultation Return Home of Patients With a Cancer (CREDO)Institut Claudius RegaudNCT02857400
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or SurgeryNational Cancer Institute (NCI)NCT02881554
Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular CancerAssistance Publique - Hôpitaux de ParisNCT02929082
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsTaiho Pharmaceutical Co. Ltd.NCT02943733
FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast CancerUniversity of Wisconsin MadisonNCT03212170
Phase I/II Trial of Regorafenib Hydroxychloroquine and Entinostat in Metastatic Colorectal CancerAbramson Cancer Center of the University of PennsylvaniaNCT03215264
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate CancerUniversity of Wisconsin MadisonNCT03232164
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney CancerMerck Sharp & Dohme Corp.NCT03260504
Patient Navigation in Cancer Survivorship at a Safety Net InstitutionBoston Medical CenterNCT03271099
PSMA PET and MRI in Gynecological CancersUniversity of Wisconsin MadisonNCT03302156
PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer PatientsNational Cancer Institute (NCI)NCT03342378
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate CancerNational Cancer Institute (NCI)NCT03358563
A Study to Test Different Doses of BI 836880 Combined With BI 754091 in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid TumoursBoehringer IngelheimNCT03468426
The Prevent Anal Cancer Self-Swab StudyBaylor College of MedicineNCT03489707
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal CancerUniversity of Wisconsin MadisonNCT03490292
Outcomes of Focal Therapies for Prostate CancerWeill Medical College of Cornell UniversityNCT03492424
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast CancerNational Cancer Institute (NCI)NCT03505671
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer ImmunotherapyInstitut Claudius RegaudNCT03514368
Defining the Molecular Profile of Breast Cancer in Uganda and Its Clinical ImplicationsFred Hutchinson Cancer Research CenterNCT03518242
Olaparib Before Surgery in Treating Participants With Localized Prostate CancerAstraZenecaNCT03570476
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate CancerAIQ SolutionsNCT03600350
The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.Institut Claudius RegaudNCT03619044
A Prospective Randomized Trial Comparing Office-based MR-guided Prostate Biopsy ApproachesWeill Medical College of Cornell UniversityNCT03632655
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCISNational Cancer Institute (NCI)NCT03703492
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung CancerCentre Leon BerardNCT03721120
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing ChemotherapyNational Cancer Institute (NCI)NCT03723863
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid CarcinomasCentre Leon BerardNCT03732495
ONC201 With and Without Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast CancerThe V Foundation for Cancer ResearchNCT03733119
Cetuximab in Head and Neck Cancer PatientsAmerican Cancer Society Inc.NCT03769311
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain MetastasesNational Cancer Institute (NCI)NCT03796273
Medical Data Collection in the Formation of Precision Oncology RegistryNational Cancer Institute (NCI)NCT03874065
Study of IMMU-132 in HR+/HER2- MBC (TROPICS-02)Immunomedics Inc.NCT03901339
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced Recurrent Platinum Resistant Ovarian Fallopian Tube or Primary Peritoneal CancerFred Hutchinson Cancer Research CenterNCT03907527
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer PatientsUniversity of Wisconsin MadisonNCT03933813
Platino-resistance in Ovarian CancerInstitut Claudius RegaudNCT03954171
Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With CancerInstitut Claudius RegaudNCT03956459
Deciphering Mechanisms Underlying Cancer ImmunogenicityInstitut Claudius RegaudNCT03958240
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral NeuropathyNational Cancer Institute (NCI)NCT03958747
A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03)Immunomedics Inc.NCT03964727
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.Institut Claudius RegaudNCT03986437
AREG EREG and EGFR: Response to Anti-EGFR Agents in Colorectal CancerNewcastle UniversityNCT03986541
Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsNational Cancer Institute (NCI)NCT03987555
Characterize Tumor Hypoxia by Magnetic Resonance ImagingNational Cancer Institute (NCI)NCT03987568
Metabolic and Microbial Profiling of Lung CancerNational Cancer Institute (NCI)NCT03998189
Exhaled Breath Analysis to Predict Risk of Symptomatic PneumonitisNational Cancer Institute (NCI)NCT04040244
The Prevent Anal Cancer Palpation StudyBaylor College of MedicineNCT04090060
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant Metastatic Prostate CancerMadison Vaccines IncNCT04090528
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck RadiotherapyKeraNetics LLCNCT04173247
FES Imaging to Optimize Tamoxifen for Metastatic Breast CancerUniversity of Wisconsin MadisonNCT04174352
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsBreast Cancer Research FoundationNCT04200482
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.Institut Claudius RegaudNCT04228432
Prevalence and Impact on QoL From Ototoxicity in Cancer SurvivorsInternational Stem Cell ForumNCT04270916
LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)UNC Lineberger Comprehensive Cancer CenterNCT04292847

Recent videos

From the Community

In The News

Get Updates on Fighting Corona AND Cancer